BMPR2 and pulmonary arterial hypertension: Subsequent to the screening of the mutational profiles of BMPR2 and of the additional PAH candidate genes included in the developed NGS panel, four patients showing no sequence variants and/or chromosomal rearrangements in the investigated genomic regions were submitted to trio-WES experiments together with their unaffected parents.